Increased High-Density Lipoprotein Cholesterol Levels in Mice With XX Versus XY Sex Chromosomes

Objective—The molecular mechanisms underlying sex differences in dyslipidemia are poorly understood. We aimed to distinguish genetic and hormonal regulators of sex differences in plasma lipid levels. Approach and Results—We assessed the role of gonadal hormones and sex chromosome complement on lipid levels using the four core genotypes mouse model (XX females, XX males, XY females, and XY males). In gonadally intact mice fed a chow diet, lipid levels were influenced by both male–female gonadal sex and XX–XY chromosome complement. Gonadectomy of adult mice revealed that the male–female differences are dependent on acute effects of gonadal hormones. In both intact and gonadectomized animals, XX mice had higher HDL cholesterol (HDL-C) levels than XY mice, regardless of male–female sex. Feeding a cholesterol-enriched diet produced distinct patterns of sex differences in lipid levels compared with a chow diet, revealing the interaction of gonadal and chromosomal sex with diet. Notably, under all dietary and gonadal conditions, HDL-C levels were higher in mice with 2 X chromosomes compared with mice with an X and Y chromosome. By generating mice with XX, XY, and XXY chromosome complements, we determined that the presence of 2 X chromosomes, and not the absence of the Y chromosome, influences HDL-C concentration. Conclusions—We demonstrate that having 2 X chromosomes versus an X and Y chromosome complement drives sex differences in HDL-C. It is conceivable that increased expression of genes escaping X-inactivation in XX mice regulates downstream processes to establish sexual dimorphism in plasma lipid levels.

[1]  Gary Tse,et al.  Animal models of atherosclerosis , 2017, Biomedical reports.

[2]  M. Oda High-density lipoprotein cholesterol: origins and the path ahead , 2015, Current opinion in endocrinology, diabetes, and obesity.

[3]  A. Kontush HDL-mediated mechanisms of protection in cardiovascular disease. , 2014, Cardiovascular research.

[4]  J. Suto,et al.  Effect of the Y chromosome on plasma high-density lipoprotein-cholesterol levels in Y-chromosome-consomic mouse strains , 2014, BMC Research Notes.

[5]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[6]  G. Shearer,et al.  HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis , 2013, PloS one.

[7]  T. Clarkson,et al.  Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future , 2013, Menopause.

[8]  A. Munnich,et al.  eIF2γ mutation that disrupts eIF2 complex integrity links intellectual disability to impaired translation initiation. , 2012, Molecular cell.

[9]  Peter Tontonoz,et al.  The Number of X Chromosomes Causes Sex Differences in Adiposity in Mice , 2012, PLoS genetics.

[10]  F. Magkos,et al.  Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. , 2011, The Journal of clinical endocrinology and metabolism.

[11]  F. Lenfant,et al.  Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed? , 2011, Maturitas.

[12]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[13]  J. Shendure,et al.  Global survey of escape from X inactivation by RNA-sequencing in mouse. , 2010, Genome research.

[14]  J. Heinecke,et al.  Exchange of Apolipoprotein A-I between Lipid-associated and Lipid-free States , 2010, The Journal of Biological Chemistry.

[15]  M. Schröder Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation. , 2010, Biochemical pharmacology.

[16]  A. Arnold The organizational–activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues , 2009, Hormones and Behavior.

[17]  A. Arnold,et al.  Mouse Models for Evaluating Sex Chromosome Effects that Cause Sex Differences in Non‐Gonadal Tissues , 2009, Journal of neuroendocrinology.

[18]  A. Arnold,et al.  What does the “four core genotypes” mouse model tell us about sex differences in the brain and other tissues? , 2009, Frontiers in Neuroendocrinology.

[19]  A. Bowie,et al.  Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKε‐mediated IRF activation , 2008, The EMBO journal.

[20]  A. Bauch,et al.  The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response , 2008, The EMBO journal.

[21]  P. Elliott,et al.  Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides , 2008, Nature Genetics.

[22]  T. Veenstra,et al.  Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases , 2007, Proceedings of the National Academy of Sciences.

[23]  Min Gyu Lee,et al.  Demethylation of H3K27 Regulates Polycomb Recruitment and H2A Ubiquitination , 2007, Science.

[24]  Howard Y. Chang,et al.  A histone H3 lysine 27 demethylase regulates animal posterior development , 2007, Nature.

[25]  J. Manson,et al.  Estrogen therapy and coronary-artery calcification. , 2007, The New England journal of medicine.

[26]  A. Rao,et al.  The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation , 2007, Nature.

[27]  J. Manson,et al.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. , 2007, JAMA.

[28]  Shumei S. Sun,et al.  Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study , 2006, International Journal of Obesity.

[29]  S. Young,et al.  A mouse monoclonal antibody specific for mouse apoB48 and apoB100 produced by immunizing "apoB39-only" mice with mouse apoB48. , 2006, Biochimica et biophysica acta.

[30]  Xiaosong Wang,et al.  Genetics of variation in HDL cholesterol in humans and mice. , 2004, Circulation research.

[31]  R. D'Agostino,et al.  Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. , 2004, Clinical chemistry.

[32]  Mary Cushman,et al.  Estrogen plus progestin and the risk of coronary heart disease. , 2003, The New England journal of medicine.

[33]  Robin Lovell-Badge,et al.  A Model System for Study of Sex Chromosome Effects on Sexually Dimorphic Neural and Behavioral Traits , 2002, The Journal of Neuroscience.

[34]  W. Toyofuku,et al.  Atherosclerosis and plasma and liver lipids in nine inbred strains of mice , 1993, Lipids.

[35]  E. Krul,et al.  In vivo regulation of apolipoprotein A-I gene expression by estradiol and testosterone occurs by different mechanisms in inbred strains of mice. , 1991, Journal of lipid research.

[36]  K. Reue,et al.  Genetic variation in mouse apolipoprotein A-IV due to insertion and deletion in a region of tandem repeats. , 1991, The Journal of biological chemistry.

[37]  G. Schonfeld,et al.  Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gel-permeation chromatography. , 1990, Metabolism: clinical and experimental.

[38]  H. Brewer,et al.  The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. , 1983, The Journal of clinical endocrinology and metabolism.

[39]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[40]  J. Qiao,et al.  Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[41]  J. Eppig,et al.  The mouse Y* chromosome involves a complex rearrangement, including interstitial positioning of the pseudoautosomal region. , 1991, Cytogenetics and cell genetics.

[42]  A. Lusis,et al.  Phenotypic characterization of the Ath-1 gene controlling high density lipoprotein levels and susceptibility to atherosclerosis. , 1990, Journal of lipid research.